These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11200823)

  • 1. Complement activation reaches maximum during equilibrium between antigen and antibody in an in vitro model for thrombolysis with streptokinase.
    Leinøe E; Pachaï A; Brandslund I
    APMIS; 2000 Oct; 108(10):685-8. PubMed ID: 11200823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of in vivo immune complex formation and complement activation in patients receiving intravenous streptokinase.
    Freysdottir J; Ormarsdottir S; Sigfusson A
    Clin Exp Immunol; 1993 Nov; 94(2):286-90. PubMed ID: 8222319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of complement and kinin systems after thrombolytic therapy in patients with acute myocardial infarction. A comparison between streptokinase and recombinant tissue-type plasminogen activator.
    Agostoni A; Gardinali M; Frangi D; Cafaro C; Conciato L; Sponzilli C; Salvioni A; Cugno M; Cicardi M
    Circulation; 1994 Dec; 90(6):2666-70. PubMed ID: 7994806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-streptokinase antibodies].
    Helft G; Lecompte T; Le Feuvre C; Metzger JP; Vacheron A; Samama MM
    Arch Mal Coeur Vaiss; 1997 Jul; 90(7):975-80. PubMed ID: 9339259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why do patients develop reactions to streptokinase?
    Lynch M; Pentecost BL; Littler WA; Stockley RA
    Clin Exp Immunol; 1993 Nov; 94(2):279-85. PubMed ID: 8222318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement-activated oligodendroglia: a new pathogenic entity identified by immunostaining with antibodies to human complement proteins C3d and C4d.
    Yamada T; Akiyama H; McGeer PL
    Neurosci Lett; 1990 May; 112(2-3):161-6. PubMed ID: 2359515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement deposition in early cardiac transplant biopsies is associated with ischemic injury and subsequent rejection episodes.
    Baldwin WM; Samaniego-Picota M; Kasper EK; Clark AM; Czader M; Rohde C; Zachary AA; Sanfilippo F; Hruban RH
    Transplantation; 1999 Sep; 68(6):894-900. PubMed ID: 10515392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway.
    Makinde VA; Senaldi G; Jawad AS; Berry H; Vergani D
    Ann Rheum Dis; 1989 Apr; 48(4):302-6. PubMed ID: 2785367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of C4d and C3d and their complex formation with serum albumin.
    Petersen NE; Teisner B; Folkersen J; Svehag SE
    Acta Pathol Microbiol Immunol Scand C; 1987 Aug; 95(4):129-35. PubMed ID: 3499750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet reactivity and streptokinase resistance following antecedent streptokinase therapy for myocardial infarction.
    Gorog DA; Ahmed N; Davies GJ
    Cardiology; 1999; 91(1):56-9. PubMed ID: 10393399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Streptokinase, complement activation and hypotension.
    Pachaï A; Erlendsson AK; Brandslund I
    APMIS; 1997 Aug; 105(8):650-4. PubMed ID: 9298105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abrupt complement activation and transient neutropenia in patients with acute myocardial infarction treated with streptokinase.
    Frangi D; Gardinali M; Conciato L; Cafaro C; Pozzoni L; Agostoni A
    Circulation; 1994 Jan; 89(1):76-80. PubMed ID: 7741820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of circulating antibodies against a streptokinase C-terminal peptide in normal blood donors.
    Ojalvo AG; Pozo L; Labarta V; Torréns I
    Biochem Biophys Res Commun; 1999 Sep; 263(2):454-9. PubMed ID: 10491315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the complement system in primary sclerosing cholangitis.
    Senaldi G; Donaldson PT; Magrin S; Farrant JM; Alexander GJ; Vergani D; Williams R
    Gastroenterology; 1989 Dec; 97(6):1430-4. PubMed ID: 2583409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The in vitro inhibitory effect of sodium selenite on complement activation].
    Li B
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Jun; 13(3):195-8. PubMed ID: 1652384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Streptokinase-induced hypotension has no detrimental effect on patients with thrombolytic treatment for acute myocardial infarction. A substudy of the Romanian Study for Accelerated Streptokinase in Acute Myocardial Infarction (ASK-ROMANIA).
    Tatu-Chiţoiu G; Teodorescu C; Dan M; Guran M; Căpraru P; Istrăţescu O; Tatu-Chiţoiu A; Bumbu A; Chioncel V; Arvanitopol S; Dorobanţu M
    Rom J Intern Med; 2004; 42(3):557-73. PubMed ID: 16366130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the classical complement pathway in brain tissue of Alzheimer patients.
    McGeer PL; Akiyama H; Itagaki S; McGeer EG
    Neurosci Lett; 1989 Dec; 107(1-3):341-6. PubMed ID: 2559373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement activation before, during and after cardiopulmonary bypass.
    Bonser RS; Dave JR; John L; Gademsetty MK; Carter PG; Davies E; Taylor P; Gaya H; Lennox SC; Vergani D
    Eur J Cardiothorac Surg; 1990; 4(6):291-6. PubMed ID: 2361017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeat thrombolysis.
    Cross D
    Aust N Z J Med; 1993 Dec; 23(6):749-52. PubMed ID: 8141718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolytic treatment and complement activation.
    Agostoni A; Gardinali M; Frangi D; Cugno M; Cafaro C; Conciato L; Sponzilli C; Salmoirago E
    Ann Ital Med Int; 1994; 9(3):178-9. PubMed ID: 7946896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.